MENU
March 31 9:00am CDT

Ultrasensitive Immunoassays: The Power of Single Molecule Counting (SMC™) Technology

As scientists continue to expand the utility of biomarkers in basic and applied life science research, advances in immunoassay technologies further empower these efforts by improving the way key markers of health and disease are identified, characterized, and measured in biological samples. In particular, recent advances of ultrasensitive assay platforms strive to enable researchers to better understand the importance and application of both novel and existing biomarkers by detecting them at levels never before possible. In doing so, scientists are able to more confidently draw meaningful conclusions regarding molecules important in early disease onset and characterize the modulation of efficacy and safety biomarkers in clinical trials, potentiating future advances in the development of therapeutics.

MilliporeSigma is excited to invite you to our upcoming virtual symposium on the power of Single Molecule Counting (SMC™) ultrasensitive immunoassay technology on March 31, 2021. Whether you are already working on the cutting edge of biomarker research, or are seeking to learn how immunoassays can enable your next scientific breakthrough, join our symposium to:

  • Learn about the relevance and utility of ultrasensitive immunoassays in life science research
  • Understand key benefits of the Single Molecule Counting (SMC™) ultrasensitive immunoassay platform
  • Explore all the ways to enjoy the power of SMC™ technology, including highly verified shelf kits, comprehensive homebrew assay development capabilities, or white-glove services offered through our expert Custom Assay and Sample Testing (CAST) team
  • Learn from leading scientists how the SMC™ platform has empowered discoveries in drug-induced immunogenicity, vaccine development, pharmacokinetics, and miRNA-based therapies
  • Network with the SMC™ user community and our in-house technology experts to spark new ideas

 


Speakers
  • Anitaben Tailor, Ph.D.

    Biology Technical Marketing, Merck
    BIOGRAPHY
  • Allison Given Chunyk

    Principal Scientist, Aptevo Therapeutics
    BIOGRAPHY
  • Sandeep Narpala

    Scientific Project Manager, Vaccine Immunology Program (VIP), Vaccine Research Center (VRC), NIAID, NIH
    BIOGRAPHY
  • Juan J. Díaz-Mochón

    Chief Scientific Officer, DESTINA
    BIOGRAPHY

You May Also Like
Agenda

Webinars

  • First Single Molecule Counting (SMC™) Application with microRNAs by a PCR Free Method
    MAR 31, 2021 11:40 AM CDT

    First Single Molecule Counting (SMC™) Application with microRNAs by a PCR Free Method

    Juan J. Díaz-Mochón
    Chief Scientific Officer, DESTINA
    BIOGRAPHY
  • A sensitive method to quantify HIV-1 antibody in mucosal samples
    MAR 31, 2021 10:50 AM CDT

    A sensitive method to quantify HIV-1 antibody in mucosal samples

    Sandeep Narpala
    Scientific Project Manager, Vaccine Immunology Program (VIP), Vaccine Research Center (VRC), NIAID, NIH
    BIOGRAPHY
  • xPLOREing possibilities on the SMCxPRO™ platform: Development of an ultra-sensitive PK assay using custom assay services.
    MAR 31, 2021 10:00 AM CDT

    xPLOREing possibilities on the SMCxPRO™ platform: Development of an ultra-sensitive PK assay using custom assay services.

    Allison Given Chunyk
    Principal Scientist, Aptevo Therapeutics
    BIOGRAPHY
  • Single Molecule Counting (SMC™) Technology Enables Acceleration of Drug Development Programs
    MAR 31, 2021 9:00 AM CDT

    Single Molecule Counting (SMC™) Technology Enables Acceleration of Drug Development Programs

    Anitaben Tailor, Ph.D.
    Biology Technical Marketing, Merck
    BIOGRAPHY

Speakers


  • Anitaben Tailor, Ph.D.

    Anitaben Tailor, Ph.D.

    Biology Technical Marketing, Merck

    BIOGRAPHY
  • Allison Given Chunyk

    Allison Given Chunyk

    Principal Scientist, Aptevo Therapeutics

    BIOGRAPHY
  • Sandeep Narpala

    Sandeep Narpala

    Scientific Project Manager, Vaccine Immunology Program (VIP), Vaccine Research Center (VRC), NIAID, NIH

    BIOGRAPHY
  • Juan J. Díaz-Mochón

    Juan J. Díaz-Mochón

    Chief Scientific Officer, DESTINA

    BIOGRAPHY
Help

Loading Comments...